01 2Excella GmbH & Co. KG
02 1Olon SpA
03 1TAPI Hungary Industries Kft.
04 1Teva Pharmaceutical Works Private Limited Company
01 3Deferoxamine Mesylate
02 2Deferoxamine mesylate
01 1Israel
02 1Italy
03 2Luxembourg
04 1Blank
NDC Package Code : 46014-1003
Start Marketing Date : 2005-09-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1127
Start Marketing Date : 2017-10-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0060
Start Marketing Date : 2015-01-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51846-1016
Start Marketing Date : 2022-01-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84671-1016
Start Marketing Date : 2022-01-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Deferoxamine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deferoxamine Mesylate, including repackagers and relabelers. The FDA regulates Deferoxamine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deferoxamine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Deferoxamine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Deferoxamine Mesylate supplier is an individual or a company that provides Deferoxamine Mesylate active pharmaceutical ingredient (API) or Deferoxamine Mesylate finished formulations upon request. The Deferoxamine Mesylate suppliers may include Deferoxamine Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Deferoxamine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Deferoxamine Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Deferoxamine Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Deferoxamine Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Deferoxamine Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Deferoxamine Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Deferoxamine Mesylate suppliers with NDC on PharmaCompass.
We have 3 companies offering Deferoxamine Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
